Written by PX1 Research Team
PX1 chemists and research educators with hands-on experience in US-based peptide manufacturing, HPLC / mass-spectrometry lot testing, and endotoxin QC. All content is citation-backed and peer-reviewed for accuracy.
The Complete Guide to SNAP-8 Peptide Research
Research Guide
Reviewed By
PX1 QC — Analytical Chemistry Team
Every article is reviewed by PX1's in-house analytical team for accuracy on mechanism, dosing ranges reported in the literature, and lab-handling guidance. We do not publish clinical or medical advice.
Quick answer
SNAP-8 (Acetyl Octapeptide-3) is a topical cosmetic peptide modeled on SNAP-25. Mechanism, formulation research, and purity considerations.
Key takeaways
- SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide developed by Lipotec, modeled on the N-terminal fragment of SNAP-25 — a SNARE protein involved in synaptic vesicle fusion.
- Purity considerations
What SNAP-8 is
SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide developed by Lipotec, modeled on the N-terminal fragment of SNAP-25 — a SNARE protein involved in synaptic vesicle fusion. It's positioned as a topical cosmetic peptide with a mechanism analogous to botulinum toxin but far weaker and delivered topically.
Mechanism
SNAP-8 competes with endogenous SNAP-25 in the SNARE complex, modestly reducing catecholamine release at the neuromuscular junction of facial muscles. Applied topically in cosmetic formulations, the effect is localized to areas of penetration.
Efficacy is orders of magnitude below botulinum toxin — SNAP-8 is a peptide, not a neurotoxin — but topical formulations report measurable smoothing of expression lines in cosmetic research.
Research findings
Manufacturer-sponsored studies of 10% SNAP-8 topical formulations over 28 days reported ~30% reduction in wrinkle depth. Independent replication is limited.
Laboratory handling
SNAP-8 is supplied lyophilized as a research peptide. It is stable at room temperature in sealed form. Research formulations typically reconstitute in aqueous solution for topical or cosmetic formulation work.
Purity considerations
Short peptides like SNAP-8 are less prone to major manufacturing errors, but N-terminal acetylation must be confirmed — a non-acetylated variant is not equivalent. LC-MS identity should verify the acetyl group's mass contribution.
Research use only.